EW β€” EDWARDS LIFESCIENCES CORP

Ownership history in TWINBEECH CAPITAL LP  Β·  13 quarters on record

This page tracks every 13F SEC filing in which TWINBEECH CAPITAL LP reported a position in EDWARDS LIFESCIENCES CORP (EW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.15% (2022 Q3)
πŸ“Š Avg. % of fund
0.38%
πŸ“… First filed
2019 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
13

Position Intelligence

TWINBEECH CAPITAL LP Γ— EW AI Analytics

πŸ“‰ TWINBEECH CAPITAL LP underperformed the S&P 500 by –25.0% annually on this EW position. Timing score: 33% (4/12 decisions correct). Average cost basis: $74.22. Maximum drawdown during holding period: –36.3%.

πŸ“ˆ Position Alpha vs SPY
-25.0%
annualised excess return

❌ Significantly underperformed the S&P 500 by 25.0% ann.
12 quarters analyzed

⏱️ Timing Score
33%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
4 of 12 add/trim decisions correct

πŸ’° Entry Quality
$74.22
+4.8% vs current ($77.77)

Best entry: $65.99 (2024 Q3)  Β·  Worst: $103.57 (2021 Q2)

πŸ›‘οΈ Drawdown Resilience
–36.3%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
62%
buy-side decisions

8 adds Β· 5 trims. Bought during 4 of 6 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
↓ Shrinking
last 4–5 quarters trend

πŸ“‰ Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.18% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    EW price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 56,905 -183,803 -76.4% 0.18% $4.4M $77.77
2024 Q3 ADDED 240,708 +157,180 +188.2% 0.30% $15.9M $65.99
2023 Q4 REDUCED 83,528 -749,263 -90.0% 0.10% $6.4M $76.25
2023 Q3 ADDED 832,791 +778,775 +1441.7% 1.11% $57.7M $69.28
2023 Q2 ADDED 54,016 +7,462 +16.0% 0.10% $5.1M $94.33
2023 Q1 REDUCED 46,554 -86,033 -64.9% 0.08% $3.9M $82.73
2022 Q4 REDUCED 132,587 -395,130 -74.9% 0.19% $9.9M $74.61
2022 Q3 ADDED 527,717 +496,111 +1569.7% 1.15% $43.6M $82.63
2022 Q2 ADDED 31,606 +4,973 +18.7% 0.13% $3.0M $95.09
2021 Q2 ADDED 26,633 +22,585 +557.9% 0.33% $2.8M $103.57
3 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding EW

As of 2025 Q4 β€” sorted by position size

2Xideas AG 3Y 10.25% Seilern Investment Management Ltd 6.1% Longaeva Partners L.P. 6.04% Nantahala Capital Management, LLC 3Y 7Y 5.07% ORBIMED ADVISORS LLC 3Y 7Y 3.21% WILSON ASSET MANAGEMENT (INTERNATIONAL) PTY LTD 3Y 3.17% Triodos Investment Management BV 3Y 7Y 3.15% Saranac Partners Ltd 3.02% WEDGEWOOD PARTNERS INC 3Y 7Y 2.88% Catalio Capital Management, LP 2.82%
← Back to TWINBEECH CAPITAL LP Holdings